{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:34:09Z","timestamp":1778538849222,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00108-018-0505-3","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T05:33:06Z","timestamp":1538458386000},"page":"1163-1179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Update endokrine Hypertonie","Update on endocrine hypertension"],"prefix":"10.1007","volume":"59","author":[{"given":"B.","family":"Lechner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"N\u00f6lting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Osswald-Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sauerbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"issue":"18","key":"505_CR1","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","volume":"289","author":"K Wolf-Maier","year":"2003","unstructured":"Wolf-Maier K et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289(18):2363\u20132369","journal-title":"JAMA"},{"issue":"9455","key":"505_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM et\u00a0al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217\u2013223","journal-title":"Lancet"},{"issue":"2","key":"505_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1210\/er.2017-00054","volume":"38","author":"JWF Young","year":"2017","unstructured":"Young JWF et\u00a0al (2017) Screening for endocrine hypertension: an Endocrine Society scientific statement. Endocr Rev 38(2):103\u2013122","journal-title":"Endocr Rev"},{"issue":"1","key":"505_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408360600931831","volume":"44","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Seccia TM, Pessina AC (2007) Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci 44(1):1\u201385","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"10","key":"505_CR5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E et\u00a0al (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J\u00a0Hypertens 34(10):1887\u20131920","journal-title":"J Hypertens"},{"issue":"5","key":"505_CR6","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW et\u00a0al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab 101(5):1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"505_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM et\u00a0al (2014) Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J\u00a0Clin Endocrinol Metab 99(6):1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"issue":"9486","key":"505_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW et\u00a0al (2005) Phaeochromocytoma. Lancet 366(9486):665\u2013675","journal-title":"Lancet"},{"issue":"5","key":"505_CR9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK et\u00a0al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J\u00a0Clin Endocrinol Metab 93(5):1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"505_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1530\/EJE-16-0967","volume":"176","author":"E Valassi","year":"2017","unstructured":"Valassi E et\u00a0al (2017) Diagnostic tests for Cushing\u2019s syndrome differ from published guidelines: data from ERCUSYN. Eur J Endocrinol 176(5):613\u2013624","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"505_CR11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra1505550","volume":"376","author":"DL Loriaux","year":"2017","unstructured":"Loriaux DL (2017) Diagnosis and differential diagnosis of Cushing\u2019s syndrome. N Engl J Med 376(15):1451\u20131459","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"505_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ecl.2005.01.008","volume":"34","author":"M Terzolo","year":"2005","unstructured":"Terzolo M et\u00a0al (2005) Subclinical Cushing\u2019s syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am 34(2):423\u2013439","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"505_CR13","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M et\u00a0al (2016) Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1\u2013G34","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"505_CR14","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","volume":"34","author":"P Mulatero","year":"2016","unstructured":"Mulatero P et\u00a0al (2016) Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J\u00a0Hypertens 34(11):2253\u20132257","journal-title":"J Hypertens"},{"issue":"3","key":"505_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno Y et\u00a0al (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71(3):530\u2013537","journal-title":"Hypertension"},{"issue":"1","key":"505_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S et al (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a\u00a0systematic review and meta-analysis. Lancet Diabetes Endocrinol 6(1):41\u201350","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"505_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF et\u00a0al (2004) Role for adrenal venous sampling in primary aldosteronism. Surgery 136(6):1227\u20131235","journal-title":"Surgery"},{"issue":"1","key":"505_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL et\u00a0al (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a\u00a0retrospective cohort study. Lancet Diabetes Endocrinol 6(1):51\u201359","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0505-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0505-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0505-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T19:26:37Z","timestamp":1569957997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0505-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["505"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0505-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"2 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Lechner, D.\u00a0Heinrich, S.\u00a0N\u00f6lting, A.\u00a0Osswald-Kopp, G.\u00a0Rubinstein, J.\u00a0Sauerbeck, F.\u00a0Beuschlein und M.\u00a0Reincke geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskriptes zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}